Bucker v. Takeda Pharmaceuticals America Inc et al
Ted Bucker and Ted Buckner |
Takeda Pharmaceuticals USA Inc, Takeda Global Research & Development Center Inc, Takeda Pharmaceuticals International Inc, Takeda Pharmaceuticals America Inc, Eli Lilly and Company and Takeda California Inc |
5:2019cv01278 |
August 9, 2019 |
US District Court for the Northern District of Alabama |
Herman N Johnson |
Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on September 23, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 11 TEXT ORDER granting #10 Motion for Extension of Time to Answer. Eli Lilly and Company answer due 11/25/2019. Signed by Magistrate Judge Herman N Johnson, Jr on 9/23/19. (LBG, ) |
Filing 10 Unopposed MOTION for Extension of Time to File Answer re #1 Complaint Motion is RIPE 9/23/2019. Any party may file a motion to reconsider within three (3) business days of a ruling on the motion.Filed by Takeda California Inc, Takeda Global Research & Development Center Inc, Takeda Pharmaceuticals America Inc, Takeda Pharmaceuticals International Inc, Takeda Pharmaceuticals USA Inc. (Eason, Leslie) |
Filing 9 Alias Summons Issued as to Eli Lilly and Company by Clerk and given to Plaintiff for service. (BJL) |
Filing 8 TEXT ORDER granting #7 Motion for Extension of Time to Answer. Takeda California, Inc. answer due 11/25/2019; Takeda Global Research & Development Center, Inc. answer due 11/25/2019; Takeda Pharmaceuticals America, Inc. answer due 11/25/2019; Takeda Pharmaceuticals International, Inc. answer due 11/25/2019; Takeda Pharmaceuticals USA, Inc. answer due 11/25/2019. Signed by Magistrate Judge Herman N Johnson, Jr on 8/29/19. (LBG, ) |
Filing 7 Unopposed MOTION for Extension of Time to File Answer re #1 Complaint or Otherwise Respond to Plaintiff's Complaint Motion is RIPE 8/29/2019. Any party may file a motion to reconsider within three (3) business days of a ruling on the motion.Filed by Takeda California Inc, Takeda Global Research & Development Center Inc, Takeda Pharmaceuticals America Inc, Takeda Pharmaceuticals International Inc, Takeda Pharmaceuticals USA Inc. (Eason, Leslie) |
Filing 6 SUMMONS Returned Executed by Ted Buckner. Takeda Pharmaceuticals International Inc served on 8/20/2019, answer due 9/10/2019. (Artrip, Eric) |
Filing 5 SUMMONS Returned Executed by Ted Buckner. Takeda Pharmaceuticals America Inc served on 8/20/2019, answer due 9/10/2019. (Artrip, Eric) |
Filing 4 SUMMONS Returned Executed by Ted Buckner. Takeda Global Research & Development Center Inc served on 8/20/2019, answer due 9/10/2019. (Artrip, Eric) |
Filing 3 SUMMONS Returned Executed by Ted Buckner. Takeda California Inc served on 8/20/2019, answer due 9/10/2019. (Artrip, Eric) |
Filing 2 Summons Issued by the clerk and hand delivered to plaintiff for service as to Eli Lilly and Company, Takeda California Inc, Takeda Global Research & Development Center Inc, Takeda Pharmaceuticals America Inc, Takeda Pharmaceuticals International Inc, and Takeda Pharmaceuticals USA Inc. (AHI) |
Filing Fee: Filing fee $ 400, receipt_number 1126-3409979 (B4601099831). related document #1 COMPLAINT with jury demand therein against All Defendants filed by Ted Buckner.(AHI ). (Mastando, Teresa) Modified on 8/14/2019 (BJL). |
Filing 1 COMPLAINT with jury demand therein against All Defendants filed by Ted Buckner.(AHI ) Modified on 8/14/2019 (BJL). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Alabama Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.